Clal Insurance Enterprises Holdings Ltd Makes New Investment in Alexandria Real Estate Equities, Inc. $ARE

Clal Insurance Enterprises Holdings Ltd purchased a new position in shares of Alexandria Real Estate Equities, Inc. (NYSE:ARE) in the second quarter, Holdings Channel reports. The fund purchased 918,000 shares of the real estate investment trust’s stock, valued at approximately $49,153,000.

Several other institutional investors and hedge funds also recently modified their holdings of ARE. BlackRock Inc. acquired a new position in shares of Alexandria Real Estate Equities during the second quarter valued at $1,146,423,000. Norges Bank acquired a new stake in Alexandria Real Estate Equities in the fourth quarter worth about $805,429,000. Invesco Ltd. lifted its holdings in Alexandria Real Estate Equities by 57.9% in the fourth quarter. Invesco Ltd. now owns 6,033,304 shares of the real estate investment trust’s stock worth $295,270,000 after purchasing an additional 2,211,424 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Alexandria Real Estate Equities by 1,022.1% in the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,813,955 shares of the real estate investment trust’s stock valued at $151,175,000 after buying an additional 1,652,298 shares in the last quarter. Finally, Bank of New York Mellon Corp acquired a new position in Alexandria Real Estate Equities during the 2nd quarter valued at about $79,253,000. Institutional investors own 96.54% of the company’s stock.

Alexandria Real Estate Equities Price Performance

Shares of Alexandria Real Estate Equities stock opened at $53.42 on Monday. The company has a current ratio of 0.19, a quick ratio of 0.19 and a debt-to-equity ratio of 0.67. The company’s 50-day moving average price is $50.58 and its two-hundred day moving average price is $49.60. Alexandria Real Estate Equities, Inc. has a 52 week low of $39.41 and a 52 week high of $88.24. The stock has a market cap of $9.31 billion, a PE ratio of -8.82 and a beta of 1.15.

Alexandria Real Estate Equities (NYSE:ARE) last issued its quarterly earnings results on Monday, August 3rd. The real estate investment trust reported ($0.43) earnings per share for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.52). Alexandria Real Estate Equities had a negative net margin of 36.08% and a negative return on equity of 5.21%. The business had revenue of $662.78 million during the quarter, compared to analyst estimates of $464.86 million. During the same period in the previous year, the company posted $2.33 earnings per share. Alexandria Real Estate Equities’s revenue was down 13.0% compared to the same quarter last year. Alexandria Real Estate Equities has set its FY 2026 guidance at 6.350-6.450 EPS. As a group, sell-side analysts anticipate that Alexandria Real Estate Equities, Inc. will post 6.38 EPS for the current fiscal year.

Alexandria Real Estate Equities Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Tuesday, June 30th were paid a dividend of $0.72 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $2.88 annualized dividend and a yield of 5.4%. Alexandria Real Estate Equities’s dividend payout ratio is currently -47.52%.

Analyst Upgrades and Downgrades

ARE has been the topic of a number of recent analyst reports. Evercore restated an “outperform” rating and set a $57.00 price target on shares of Alexandria Real Estate Equities in a research report on Monday, August 17th. Citizens Jmp reiterated a “market perform” rating on shares of Alexandria Real Estate Equities in a report on Monday, August 17th. The Goldman Sachs Group reiterated a “neutral” rating and set a $52.00 price objective on shares of Alexandria Real Estate Equities in a research note on Tuesday, May 19th. Robert W. Baird reissued a “neutral” rating and set a $46.00 target price (down from $67.00) on shares of Alexandria Real Estate Equities in a report on Monday, May 4th. Finally, Citigroup upped their target price on Alexandria Real Estate Equities from $42.00 to $50.00 and gave the stock a “neutral” rating in a research report on Monday, August 10th. Two analysts have rated the stock with a Buy rating, eleven have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and an average price target of $52.38.

Insider Activity at Alexandria Real Estate Equities

In other Alexandria Real Estate Equities news, CFO Marc E. Binda sold 2,000 shares of the company’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $54.00, for a total value of $108,000.00. Following the transaction, the chief financial officer owned 188,264 shares of the company’s stock, valued at approximately $10,166,256. This represents a 1.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Chairman Joel S. Marcus purchased 5,000 shares of the company’s stock in a transaction on Monday, August 17th. The stock was bought at an average cost of $46.28 per share, for a total transaction of $231,400.00. Following the acquisition, the chairman directly owned 592,724 shares of the company’s stock, valued at $27,431,266.72. This represents a 0.85% increase in their position. The disclosure for this purchase is available in the SEC filing. 1.35% of the stock is owned by corporate insiders.

Alexandria Real Estate Equities Profile

Alexandria Real Estate Equities, Inc (NYSE: ARE) is a real estate investment trust specializing in the ownership, development and management of collaborative life science and technology campuses. The company’s properties are designed to support research and innovation by providing specialized laboratory, office and manufacturing space tailored to biotechnology, pharmaceutical, academic and related industries.

Since its founding in 1994, Alexandria has cultivated a diversified portfolio of campuses across leading innovation clusters in North America and Europe.